Federal investment in basic science built America’s innovation engine, but declining support is threatening U.S. leadership, ...
Flashpoint Therapeutics, a biotechnology company pioneering the development of transformative nanomedicines, proudly congratulates its founder, Professor Chad A. Mirkin, on being named the recipient ...
Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC.
More than a quarter of the world's population is affected by helminth infections, which can profoundly alter the immune ...
Updated 2025-2026 formulations of mRNA-1283 and BNT162b2 protect older adults against severe COVID-19 outcomes and medically attended illness.
Morning Overview on MSN
A personalized melanoma vaccine cut recurrence risk by 49% in a Moderna and Merck trial
Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside the immunotherapy drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results